NSC |
Compound |
Enrichment |
Correlation |
NSC 732205 |
Null |
0.029142074732756 |
0.43223839 |
NSC 734949 |
4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide |
0.029142074732756 |
0.11912602 |
NSC 735472 |
(2E,8S,9Z)-2,9,16-heptadecatrien-4,6-diyn-1,8-diol |
0.029142074732756 |
0.17943396 |
NSC 740357 |
Null |
0.029142074732756 |
0.15445447 |
NSC 744023 |
(11aS)-8-(3-{4-[(E)-3-(2-hydroxyphenyl)-3-oxo-1-propenyl]-2-methoxyphenoxy}propoxy)-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one |
0.029142074732756 |
0.16054567 |
NSC 750100 |
4-[5-(phenyl)-3-(methylselenocyanide) pyrazol-1-yl]benzenesulfonamide |
0.029142074732756 |
-0.182133 |
NSC 200692 |
Aspiculamycin hydrochloride |
0.0295480456086945 |
-0.33972896 |
NSC 622579 |
Carbamimidothioic acid, N,N-dimethyl-N'-[(phenylimino) (methylthio)methyl]-, phenylmethyl ester, hydroiodide |
0.0295480456086945 |
0.5581176 |
NSC 626388 |
Null |
0.0295480456086945 |
-0.10699201 |
NSC 662383 |
2-Bromo-5,8-dihydroxy-3-methyl-1,4-naphthoquinone |
0.0295480456086945 |
0.55092447 |